COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CHCT - US20369C1062 - REIT
16.89 USD
+0.04 (+0.24%)
16.65 USD
-0.24 (-1.42%)
We assign a fundamental rating of 3 out of 10 to CHCT. CHCT was compared to 126 industry peers in the Diversified REITs industry. CHCT has a bad profitability rating. Also its financial health evaluation is rather negative. CHCT is valied quite expensively at the moment, while it does show a decent growth rate. CHCT also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHCT has reported negative net income.
In the past year CHCT had a positive cash flow from operations.
Of the past 5 years CHCT 4 years were profitable.
Each year in the past 5 years CHCT had a positive operating cash flow.
1.2 Ratios
CHCT's Return On Assets of -1.06% is on the low side compared to the rest of the industry. CHCT is outperformed by 67.46% of its industry peers.
CHCT has a worse Return On Equity (-2.46%) than 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.27%, CHCT is in line with its industry, outperforming 42.86% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHCT is in line with the industry average of 3.06%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.46% | ||
| ROIC | 2.27% |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
1.3 Margins
CHCT's Operating Margin of 23.26% is in line compared to the rest of the industry. CHCT outperforms 51.59% of its industry peers.
CHCT's Operating Margin has declined in the last couple of years.
The Gross Margin of CHCT (80.68%) is better than 81.75% of its industry peers.
CHCT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.26% | ||
| PM (TTM) | N/A | ||
| GM | 80.68% |
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHCT is destroying value.
CHCT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CHCT has been increased compared to 5 years ago.
Compared to 1 year ago, CHCT has a worse debt to assets ratio.
2.2 Solvency
CHCT has an Altman-Z score of 0.82. This is a bad value and indicates that CHCT is not financially healthy and even has some risk of bankruptcy.
CHCT's Altman-Z score of 0.82 is fine compared to the rest of the industry. CHCT outperforms 67.46% of its industry peers.
A Debt/Equity ratio of 1.25 is on the high side and indicates that CHCT has dependencies on debt financing.
With a Debt to Equity ratio value of 1.25, CHCT perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.82 |
ROIC/WACC0.34
WACC6.76%
2.3 Liquidity
CHCT has a Current Ratio of 0.47. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
CHCT has a worse Current ratio (0.47) than 80.95% of its industry peers.
A Quick Ratio of 0.16 indicates that CHCT may have some problems paying its short term obligations.
CHCT's Quick ratio of 0.16 is on the low side compared to the rest of the industry. CHCT is outperformed by 92.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.16 |
3. Growth
3.1 Past
CHCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -146.88%.
CHCT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.22% yearly.
Looking at the last year, CHCT shows a very negative growth in Revenue. The Revenue has decreased by -17.52% in the last year.
Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 13.73% on average per year.
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%
3.2 Future
The Earnings Per Share is expected to grow by 42.04% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.35% on average over the next years. This is quite good.
EPS Next Y-216.57%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y5.36%
Revenue Next 3Y6.45%
Revenue Next 5Y9.35%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CHCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 35.23, which means the current valuation is very expensive for CHCT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHCT indicates a somewhat cheap valuation: CHCT is cheaper than 71.43% of the companies listed in the same industry.
CHCT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 35.23 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHCT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 14.16 |
4.3 Compensation for Growth
CHCT's earnings are expected to grow with 42.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.09%
EPS Next 3Y42.04%
5. Dividend
5.1 Amount
CHCT has a Yearly Dividend Yield of 11.23%, which is a nice return.
CHCT's Dividend Yield is rather good when compared to the industry average which is at 6.86. CHCT pays more dividend than 96.03% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, CHCT pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.23% |
5.2 History
The dividend of CHCT has a limited annual growth rate of 2.99%.
CHCT has been paying a dividend for at least 10 years, so it has a reliable track record.
CHCT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.99%
Div Incr Years9
Div Non Decr Years9
5.3 Sustainability
CHCT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHCT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-507.68%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
16.89
+0.04 (+0.24%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners83.09%
Inst Owner Change0.01%
Ins Owners5.89%
Ins Owner Change3.95%
Market Cap480.86M
Revenue(TTM)119.55M
Net Income(TTM)-10.49M
Analysts81.82
Price Target18.16 (7.52%)
Short Float %3.23%
Short Ratio3.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.23% |
Yearly Dividend1.85
Dividend Growth(5Y)2.99%
DP-507.68%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.89%
Min EPS beat(2)-88.54%
Max EPS beat(2)-63.24%
EPS beat(4)0
Avg EPS beat(4)-63.43%
Min EPS beat(4)-88.54%
Max EPS beat(4)-43.98%
EPS beat(8)0
Avg EPS beat(8)-53.34%
EPS beat(12)1
Avg EPS beat(12)-60.44%
EPS beat(16)1
Avg EPS beat(16)-48.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.38%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-3.64%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-3.34%
Revenue beat(12)1
Avg Revenue beat(12)-2.84%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)0%
PT rev (3m)-6.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 35.23 | ||
| P/S | 4.02 | ||
| P/FCF | N/A | ||
| P/OCF | 8.5 | ||
| P/B | 1.13 | ||
| P/tB | 1.13 | ||
| EV/EBITDA | 14.16 |
EPS(TTM)-0.15
EYN/A
EPS(NY)0.48
Fwd EY2.84%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)1.99
OCFY11.77%
SpS4.2
BVpS14.99
TBVpS14.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.46% | ||
| ROCE | 2.88% | ||
| ROIC | 2.27% | ||
| ROICexc | 2.28% | ||
| ROICexgc | 2.32% | ||
| OM | 23.26% | ||
| PM (TTM) | N/A | ||
| GM | 80.68% | ||
| FCFM | N/A |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
ROICexc(3y)2.61%
ROICexc(5y)2.94%
ROICexgc(3y)2.69%
ROICexgc(5y)3%
ROCE(3y)3.28%
ROCE(5y)3.7%
ROICexgc growth 3Y-9.66%
ROICexgc growth 5Y-0.75%
ROICexc growth 3Y-10.19%
ROICexc growth 5Y-1.2%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
F-Score3
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.48 | ||
| Cap/Depr | 145.76% | ||
| Cap/Sales | 53.07% | ||
| Interest Coverage | 1.1 | ||
| Cash Conversion | 79.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.16 | ||
| Altman-Z | 0.82 |
F-Score3
WACC6.76%
ROIC/WACC0.34
Cap/Depr(3y)284.94%
Cap/Depr(5y)339.12%
Cap/Sales(3y)99.29%
Cap/Sales(5y)115.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
EPS Next Y-216.57%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%
Revenue Next Year4.74%
Revenue Next 2Y5.36%
Revenue Next 3Y6.45%
Revenue Next 5Y9.35%
EBIT growth 1Y-32.49%
EBIT growth 3Y-1.85%
EBIT growth 5Y10.76%
EBIT Next Year265.38%
EBIT Next 3Y62.68%
EBIT Next 5YN/A
FCF growth 1Y92.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.45%
OCF growth 3Y1.48%
OCF growth 5Y12.72%
COMMUNITY HEALTHCARE TRUST I / CHCT FAQ
What is the fundamental rating for CHCT stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHCT.
What is the valuation status for CHCT stock?
ChartMill assigns a valuation rating of 2 / 10 to COMMUNITY HEALTHCARE TRUST I (CHCT). This can be considered as Overvalued.
What is the profitability of CHCT stock?
COMMUNITY HEALTHCARE TRUST I (CHCT) has a profitability rating of 3 / 10.
Can you provide the financial health for CHCT stock?
The financial health rating of COMMUNITY HEALTHCARE TRUST I (CHCT) is 1 / 10.